Skip to main content
. 2020 May 21;4(3):e363. doi: 10.1097/HS9.0000000000000363

Figure 1.

Figure 1

Cumulative incidence of ibrutinib initiation starting at the time of Waldenström macroglobulinemia diagnosis.